Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $73.83 | 5 | 85.3% |
| Education | $12.74 | 1 | 14.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $57.94 | 4 | $0 (2017) |
| Mitsubishi Tanabe Pharma America, Inc. | $28.63 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $86.57 | 6 | Allergan Inc. ($57.94) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2017 | Mitsubishi Tanabe Pharma America, Inc. | Radicava (Drug) | Education | In-kind items and services | $12.74 | General |
| Category: Amyotrophic Lateral Sclerosis | ||||||
| 08/29/2017 | Mitsubishi Tanabe Pharma America, Inc. | Radicava (Drug) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: Amyotrophic Lateral Sclerosis | ||||||
| 06/13/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 297 | 476 | $67,109 | $31,060 |
| 2022 | 9 | 430 | 634 | $80,593 | $40,446 |
| 2021 | 7 | 476 | 704 | $79,755 | $52,284 |
| 2020 | 10 | 529 | 772 | $89,663 | $44,514 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 224 | 371 | $53,625 | $24,541 | 45.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 18 | $3,872 | $1,920 | 49.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $3,236 | $1,770 | 54.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 34 | $2,552 | $1,589 | 62.3% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 15 | 36 | $3,824 | $1,241 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 259 | 425 | $52,036 | $27,335 | 52.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $6,608 | $2,495 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $4,947 | $2,227 | 45.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 24 | $4,425 | $2,226 | 50.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 46 | $3,332 | $2,200 | 66.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $4,068 | $2,059 | 50.6% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2022 | 15 | 31 | $3,255 | $999.67 | 30.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 27 | $918.00 | $635.45 | 69.2% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 11 | 22 | $1,004 | $269.85 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 271 | 446 | $47,276 | $32,479 | 68.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 48 | 54 | $8,304 | $6,197 | 74.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 65 | $7,809 | $4,763 | 61.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 32 | 32 | $7,602 | $4,592 | 60.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 27 | 32 | $2,176 | $1,682 | 77.3% |
| 95983 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, first 15 minutes face-to-face time with qualified health care professional | Facility | 2021 | 16 | 36 | $3,780 | $1,453 | 38.4% |
| 95984 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, additional 15 minutes face-to-face time with qualified health care professional | Facility | 2021 | 12 | 25 | $2,275 | $891.50 | 39.2% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Facility | 2021 | 11 | 14 | $532.00 | $224.70 | 42.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 305 | 503 | $53,318 | $26,952 | 50.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 50 | 50 | $11,502 | $6,283 | 54.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 40 | 42 | $6,300 | $3,137 | 49.8% |
About Dr. William Stamey, MD
Dr. William Stamey, MD is a Neurology healthcare provider based in Brunswick, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093874893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Stamey, MD has received a total of $86.57 in payments from pharmaceutical and medical device companies, with $86.57 received in 2017. These payments were reported across 6 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($73.83).
As a Medicare-enrolled provider, Stamey has provided services to 1,732 Medicare beneficiaries, totaling 2,586 services with total Medicare billing of $168,304. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Brunswick, ME
- Active Since 12/07/2006
- Last Updated 02/12/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1093874893
Products in Payments
- NAMZARIC (Drug) $42.83
- Radicava (Drug) $28.63
- VRAYLAR (Drug) $15.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brunswick
Dr. Phillip Amodeo, M.d, M.D
Neurology — Payments: $37,145
Lori Trefts, M.d, M.D
Neurology — Payments: $24,016
Kathryn Seasholtz, Do, DO
Neurology — Payments: $208.97
Jacques Reynolds, D.o, D.O
Neurology — Payments: $18.61
Veronica Sanchez, Pt, Dpt, PT, DPT
Neurology
Dr. Elizabeth Mcnally, Dc. Dacnb, DC. DACNB
Neurology